Viewing nowCombinationRodient Tablet 80/5 mg (Telmisartan, Esamlodipine Nicotinic Acid Salt)
Telmisartan 80mg · S-Amlodipine Nicotinate 6.506mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.

MFDS item code 202104292 · Approved 2021.05.31 · Insurance code 645306550
Treatment of essential hypertension not controlled with monotherapy
This medication is used for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled by monotherapy with esamlodipine (amlodipine) or telmisartan. It effectively lowers blood pressure, reduces the risk of cardiovascular diseases, and helps maintain a healthy blood pressure level.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (S-amlodipine (amlodipine) or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/2.5mg: For patients whose blood pressure is not adequately controlled with 2.5mg of S-amlodipine (5mg of amlodipine) or 40mg of telmisartan. - 80/2.5mg: For patients whose blood pressure is not adequately controlled with 2.5mg of S-amlodipine (5mg of amlodipine) or this medicine 40/2.5mg. - 40/5mg: For patients whose blood pressure is not adequately controlled with 5mg of S-amlodipine (10mg of amlodipine). - 80/5mg: For patients whose blood pressure is not adequately controlled with 5mg of S-amlodipine (10mg of amlodipine) or this medicine 40/5mg. Patients taking telmisartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience (only for this medicine 40/2.5mg and 80/5mg). O Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. O Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40mg in patients with mild or moderate hepatic impairment. O Elderly patients: The usual dosage regimen of S-amlodipine (amlodipine) is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Administration with caution in the following patients’). In elderly patients aged 75 years or older, clearance of S-amlodipine (amlodipine) is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can cause severe harm to the fetus during pregnancy, especially in the second and third trimesters, and should not be taken by pregnant women or women who may become pregnant. Patients with allergies to any components of this drug or those with certain heart diseases, severe liver or kidney impairment should not take this medication. Caution is advised when using this medication in patients with liver impairment or gastrointestinal diseases, and care should be taken in patients with severely low blood pressure or severe heart diseases. Side effects such as dizziness or edema may occur during the use of this drug, and in severe cases may lead to fainting or heart problems. As this drug lowers blood pressure, hypotension may occur, particularly in patients with low body fluids or salts, caution is necessary at the initial stage of treatment. There is an increased risk of elevated potassium levels in the blood, so care should be taken when taken with potassium supplements or drugs containing potassium. Patients with poor kidney function should have their kidney function monitored regularly while taking this medication, and patients with heart diseases or diabetes should take it carefully according to a doctor's instructions. This medication may cause drowsiness or dizziness, so caution is necessary when driving or operating machinery. Interactions may occur when taken with other antihypertensive drugs or certain medications, so consultation with a doctor or pharmacist is essential. In case of overdose, severe hypotension or heart problems may occur, so the prescribed dosage must be strictly followed, and if any unusual symptoms arise, medical personnel should be informed immediately. Special care is required when this medication is taken by children or the elderly, and dosage adjustments can be made for the elderly. This medication should be kept out of the reach of children, and transferring it to another container is not recommended as it may compromise the quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is advisable to store it at room temperature between 1 to 30 degrees Celsius to maintain its effectiveness.
Light blue and white oval-shaped tablet consisting of two layers
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · S-Amlodipine Nicotinate 6.506mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · S-Amlodipine Nicotinate 3.253mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · S-Amlodipine Nicotinate 6.506mg
Tablet · Prescription medication · Combination
Hallym Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · S-Amlodipine Nicotinate 3.253mg
Tablet · Prescription medication · Combination
Hallym Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.